SOPHARMA (SPH): Sales revenues for April 2018 - raport 20
Raport ESPI
UNI - EN REPORT No
20
/
2018
UNI - EN REPORT No20/2018
Sopharma AD (the “Company”) notifies that for April 2018 the Company recorded an increase of sales revenues of 12% compared to the same month of 2017, including 1% increase of domestic sales and an increase of 21% of export sales.
For the first four months of this year, revenues from sales of products increased by 0,3% compared to the same period of 2017, including 0.5% increase of domestic sales and 0,1% increase of export sales.
